GNE-617 |
GNE-617 : Inhibitor of NAMPT
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| NAMPT |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Assessed for CYP inhibition, GNE-617 shows an IC50 of 200 nM against CYP2C9 (warfarin metabolism ass ...
Potency Cellular
In Vitro
NAMPT
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm4008664
In Vivo Validations
Mouse
Dose: 5 mg/Kg
Route of delivery:
Intravenous
Systemic clearance:
52.4 mL/min/kg
Volume of Distribution at Steady-State:
6.7 L/kg
DOI Reference: 10.1021/jm4008664
Dose: 10 mg/Kg
Route of delivery:
Oral
Cmax:
1.21 uM
Tmax:
0.25 h
Area Under the Curve::
3.06 μM*h
Bioavailability:
41.1%
DOI Reference: 10.1021/jm4008664
Chemical Information
| Molecular Formula | C21H15F2N3O3S |
| SMILEs | O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1ccc2nccn2c1 |
| InChI | InChI=1S/C21H15F2N3O3S/c22-16-9-17(23)11-19(10-16)30(28,29)18-4-1-14(2-5-18)12-25-21(27)15-3-6-20-24-7-8-26(20)13-15/h1-11,13H,12H2,(H,25,27) |
| Molecular weight | 427.08 Da |
| AlogP | 3.375300000000002 |
| HBond acceptors | 6 |
| HBond donors | 1 |
| Atoms | 45 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.